dc.contributor.author |
Buonfrate, D. |
|
dc.contributor.author |
Angheben, A. |
|
dc.contributor.author |
Gobbi, F. |
|
dc.contributor.author |
Muñoz, J. |
|
dc.contributor.author |
Requena-Mendez, A. |
|
dc.contributor.author |
Gotuzzo Herencia, José Eduardo |
|
dc.contributor.author |
Mena, M.A. |
|
dc.contributor.author |
Bisoffi, Z. |
|
dc.date.accessioned |
2022-01-18T19:26:45Z |
|
dc.date.available |
2022-01-18T19:26:45Z |
|
dc.date.issued |
2012 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/10832 |
|
dc.description.abstract |
Strongyloidiasis is extremely more frequent in immigrants than in travellers. Clinical presentations do not differ significantly between the two groups, and the most frequent picture is a chronic infection characterized by intermittent, mild, non-specific symptoms. Acute presentation is rare but it has been reported in travellers. Screening of asymptomatic subjects is not generally recommended, while a presumptive treatment with ivermectin might be justified for all travellers and immigrant patients presenting unexplained eosinophilia and/or compatible symptoms, even in case of negative test results. In fact, delayed diagnosis and treatment has life-threatening consequences in patients with conditions predisposing to development of hyperinfection and dissemination. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Springer |
|
dc.relation.ispartofseries |
Current Infectious Disease Reports |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Risk Assessment |
en_US |
dc.subject |
Disease Association |
en_US |
dc.subject |
Abdominal Pain |
en_US |
dc.subject |
Diarrhea |
en_US |
dc.subject |
Drug Efficacy |
en_US |
dc.subject |
Drug Megadose |
en_US |
dc.subject |
Incidence |
en_US |
dc.subject |
Prevalence |
en_US |
dc.subject |
Albendazole |
en_US |
dc.subject |
Eosinophilia |
en_US |
dc.subject |
Strongyloidiasis |
en_US |
dc.subject |
Infection Risk |
en_US |
dc.subject |
Clinical Feature |
en_US |
dc.subject |
Drug Dose Comparison |
en_US |
dc.subject |
Dose Response |
en_US |
dc.subject |
Dyspnea |
en_US |
dc.subject |
Travel |
en_US |
dc.subject |
Drug Tolerability |
en_US |
dc.subject |
Single Drug Dose |
en_US |
dc.subject |
Coughing |
en_US |
dc.subject |
Ivermectin |
en_US |
dc.subject |
Rash |
en_US |
dc.subject |
Strongyloides Stercoralis |
en_US |
dc.subject |
Urticaria |
en_US |
dc.subject |
Immigrants |
en_US |
dc.subject |
Imported |
en_US |
dc.subject |
Loeffler Pneumonia |
en_US |
dc.subject |
Refugee |
en_US |
dc.subject |
Skin Pruritus |
en_US |
dc.subject |
Travellers |
en_US |
dc.title |
Imported strongyloidiasis: Epidemiology, presentations, and treatment |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1007/s11908-012-0248-6 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.08 |
|
dc.relation.issn |
1534-3146 |
|